Steve Harr, M.D., is the former chief financial officer and head of corporate development for Juno Therapeutics; he joined the organization in 2014. Before joining Juno, Dr. Harr was managing director and head of biotechnology investment banking at Morgan Stanley for approximately four years, with a previous position at the firm as their lead biotech research analyst and co-head of their global healthcare research arm. Dr. Harr received a B.A. in economics from College of the Holy Cross and an M.D. from the Johns Hopkins University School of Medicine. He was a resident in internal medicine at the University of California, San Francisco.